Sentinel Node And Recurrent Breast cancer
Recruiting
- Conditions
- Recurrent breast cancerSentinel node biopsieRecidief mammacarcinoomSchildwachtklierprocedure
- Registration Number
- NL-OMON22722
- Lead Sponsor
- The principal investigator of this study is mrs. A. Maaskant-Braat, resident surgery
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 150
Inclusion Criteria
1. Women above 18 years old with locally recurrent breast cancer after earlier BCT or modified radical mastectomy.
2. Operable cytological /histological confirmed locally recurrent breast cancer.
Exclusion Criteria
1. Proven ipsi- or contralateral regional lymph node metastases (ultrasound and FNA).
2. Known to be allergic to 99mTc-colloidal albumin” or blue dye injection fluids.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method - Registration of technical feasibility of lymphatic mapping and sentinel node biopsy in patients with locally recurrent breast cancer.<br /><br>- Registration of success rate of lymphatic mapping and SNB in patients with locally recurrent breast cancer.<br /><br>- Registration of validity of lymphatic mapping and sentinel node biopsy in patients with locally recurrent breast cancer. <br><br><br>
- Secondary Outcome Measures
Name Time Method - Registration of lymphatic drainage pathways in patients with locally recurrent breast cancer. <br /><br>- Registration of sentinel lymph node status in patients with locally recurrent breast cancer. <br /><br>- Registration of possible influence of lymphatic mapping and SNB on therapeutic decisions in patients with locally recurrent breast cancer. <br /><br><br>